2-Bromo-4-methylthiazole-5-carbonitrile, 97.0%, 250mg

5-Phenyl-3-n-propyl-1,2,4-oxadiazole, 1g

Methyl 2-aminooxazole-4-carboxylate, 95.0%, 100g

Dipropylene glycol monobutyl ether, min 98%, for synthesis, 5L, plastic packaging.

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid, 95.0%, 5g

4-Chlorobenzo[d]thiazole-2-carbonitrile, 95.0%, 100mg

(4-(Benzyloxy)-3-methoxyphenyl)methanol, 95+%, 5g

6-TERT-BUTYL 1-METHYL 6-AZASPIRO[2.5]OCTANE-1,6-DICARBOXYLATE, 95.0%, 250mg

N,N,N',N'-Tetramethylbenzidine>98.0%(GC)(T)5g

5-(chloromethyl)-2-methanesulfonyl-1-pentyl-1H-imidazole, 95.0%, 10g

tert-Butyl 4-(1-hydroxypropan-2-yl)piperazine-1-carboxylate, 98%, 500mg

Methyl 4-methoxy-2-methylbenzoate, 95.0%, 10g

Bicyclo[3.3.1]nonan-9-one, 98%, 100mg